Benefit of Concurrent Versus Sequential Chemoradiotherapy in Elderly Patients With Stage III Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Benefit of Concurrent Versus Sequential Chemoradiotherapy in Elderly Patients With Stage III Non-Small Cell Lung Cancer

Published:2021-12 Issue: Volume: Page:
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Logtenberg Marleen E.^ORCID,Tomlow Ben,Kastelijn Elisabeth A.,Schramel Franz M.N.H.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. International Association for the Study of Lung Cancer. 8th Edition Lung Cancer TNM Staging Summary International Association for the Study of Lung Cancer. 2016:1.

3. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non - small-cell lung cancer;Aupérin;J Clin Oncol,2010

4. Treatment variation of sequential versus concurrent chemoradiotherapy in stage III non-small cell lung cancer patients in the Netherlands and Belgium;Walraven;Clin Oncol,2017

5. Pooled analysis of individual patient data on concurrent chemoradiotherapy for stage III non-small-cell lung cancer in elderly patients compared with younger patients who participated in US national cancer institute cooperative group studies;Stinchcombe;J Clin Oncol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials;Cancer Treatment Reviews;2024-09

2. The impact of different modalities of chemoradiation therapy and chemotherapy regimens on lymphopenia in patients with locally advanced non-small cell lung cancer;Translational Lung Cancer Research;2024-06